Assistant Professor of Biomedical Engineering Adam Gormley and doctoral student Matthew Tamasi are developing biomedical technology that aims to destroy tumors using polymers that are so advanced they can be made very small and sent into the bloodstream to target cancer. Watch the report on News 12 New Jersey.
Recent Posts
- Join Clinical Trials Day at Rutgers on 5/20
- NJ ACTS Success Story – The Kiosk Project
- Doctors Explain How to Tell the Difference Between Cold, Flu, and COVID-19 Symptoms.
- NJACTS Community Engagement Core COVID-19 Resources
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD)on 5/28 at 12pm
Categories
- Community (2,489)
- Covid (1,001)
- CTO Events (6)
- News (3,161)
- Pilots (21)